Apoptosis induced by aminoglycosides in LLC-PK1 cells: Comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 6, 2008, Pages 2236-2238

  Denamur, Sophie ^a   Van Bambeke, Françoise ^a   Mingeot Leclercq, Marie Paule ^a   Tulkens, Paul M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4',6' DIAMIDINO 2 PHENYLINDOLE; AMIKACIN; CASPASE 3; GENTAMICIN; INDOLE DERIVATIVE; ISEPAMICIN; NEOMYCIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; ELECTROPORATION; ENZYME ACTIVATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

AMIKACIN; AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; ELECTROPORATION; GENTAMICINS; LLC-PK1 CELLS; NEOMYCIN; SWINE;

EID: 44449161986     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01680-07     Document Type: Article

References (26)

1. Anonymous. 1999. Tackling antimicrobial resistance. Drug Ther. Bull. 37:9-16.
2. Arany, I., and R. L. Safirstein. 2003. Cisplatin nephrotoxicity. Semin. Nephrol. 23:460-464.
3. Choi, K. H., T. I. Kim, D. L. Chong, H. Y. Lee, and D. S. Han. 2000. Gentamicin induced apoptosis of renal tubular epithelial (LLC-PK1) cells. Korean J. Intern. Med. 15:218-223.
4. El Mouedden, M., G. Laurent, M. P. Mingeot-Leclercq, H. S. Taper, J. Cumps, and P. M. Tulkens. 2000. Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides. Antimicrob. Agents Chemother. 44:665-675.
5. El Mouedden, M., G. Laurent, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2000. Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol. Sci. 56:229-239.
6. Gehl, J. 2003. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 177:437-447.
7. Gilbert, D. N. 2005. Aminoglycosides, p. 328-356. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Elsevier/Churchill Livingstone, Philadelphia, PA.
8. Hottendorf, G. H., and L. L. Gordon. 1980. Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin. Antimicrob. Agents Chemother. 18:176-181.
9. Juan, S. H., C. H. Chen, Y. H. Hsu, C. C. Hou, T. H. Chen, H. Lin, Y. L. Chu, and Y. M. Sue. 2007. Tetramethylpyrazine protects rat renal tubular cell apoptosis induced by gentamicin. Nephrol. Dial. Transplant. 22:732-739.
10. Laurent, G., M. B. Carlier, B. Rollman, F. Van Hoof, and P. Tulkens. 1982. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31:3861-3870.
11. Livermore, D. M. 2003. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36:S11-S23.
12. Mingeot-Leclercq, M. P., Y. Glupczynski, and P. M. Tulkens. 1999. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727-737.
13. Mingeot-Leclercq, M. P., and P. M. Tulkens. 1999. Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother. 43:1003-1012.
14. Moestrup, S. K., S. Cui, H. Vorum, C. Bregengard, S. E. Bjorn, K. Norris, J. Gliemann, and E. I. Christensen. 1995. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J. Clin. Investig. 96:1404-1413.
15. Rankin, L. I., F. C. Luft, M. N. Yum, R. S. Sloan, C. B. Dinwiddie, Jr., and L. L. Isaacs. 1979. Comparative nephrotoxicity of SCH 21420 and amikacin in rats. Antimicrob. Agents Chemother. 16:491-494.
16. Ryu, D. H., A. Litovchick, and R. R. Rando. 2002. Stereospecificity of aminoglycoside-ribosomal interactions. Biochemistry 41:10499-10509.
17. Saboliæ, I. 2006. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol. 104:107-114.
18. Sandoval, R. M., and B. A. Molitoris. 2004. Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am. J. Physiol. Renal Physiol. 286:F617-F624.
19. Schmitz, C., J. Hilpert, C. Jacobsen, C. Boensch, E. I. Christensen, F. C. Luft, and T. E. Willnow. 2002. Megalin deficiency offers protection from renal aminoglycoside accumulation. J. Biol. Chem. 277:618-622.
20. Servais, H., Y. Jossin, F. Van Bambeke, P. M. Tulkens, and M. P. Mingeot-Leclercq. 2006. Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob. Agents Chemother. 50:1213-1221.
21. Servais, H., A. Ortiz, O. Devuyst, S. Denamur, P. M. Tulkens, and M.-P. Mingeot-Leclercq. 2008. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 13:11-32.
22. Servais, H., P. Van Der Smissen, G. Thirion, G. Van der Essen, F. Van Bambeke, P. M. Tulkens, and M.-P. Mingeot-Leclercq. 2005. Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol. Appl. Pharmacol. 206:321-333.
23. Silva, J. G., and I. Carvalho. 2007. New insights into aminoglycoside antibiotics and derivatives. Curr. Med. Chem. 14:1101-1119.
24. Talbot, G. H., J. Bradley, J. E. Edwards, Jr., D. Gilbert, M. Scheid, and J. G. Bartlett. 2006. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42:657-668.
25. Tulkens, P. M. 1986. Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives. Am. J. Med. 80:105-114.
26. Yang, G., J. Trylska, Y. Tor, and J. A. McCammon. 2006. Binding of aminoglycosidic antibiotics to the oligonucleotide A-site model and 30S ribosomal subunit: Poisson-Boltzmann model, thermal denaturation, and fluorescence studies. J. Med. Chem. 49:5478-5490.